体细胞基因突变对骨髓纤维化患者血栓形成风险的影响。 - Suppr

Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.

作者信息

Pastor-Galán Irene, Pereira Arturo, Arellano-Rodrigo Eduardo, Martín Iván, Mosquera-Orgueira Adrián, Gómez-Casares María-Teresa, Hernández-Sánchez Alberto, Ferrer-Marín Francisca, Mora Elvira, Velez Patricia, Ayala Rosa, Angona Anna, de Las Heras Natalia, Magro Elena, Mata-Vázquez María-Isabel, Fox María-Laura, González de Villambrosía Sonia, Ramírez María-José, García Ana, García-Gutiérrez Valentín, Cáceres Amparo, Durán María-Antonia, Senín María-Alicia, Raya José-María, González José Antonio, Cuevas Beatriz, Xicoy Blanca, Garrote Marta, Ferrer Blanca, Pérez-Encinas Manuel, Hernández-Rivas Jesús María, Bellosillo Beatriz, Álvarez-Larrán Alberto, Hernández-Boluda Juan Carlos

机构信息

Hospital Clínico Universitario-INCLIVA, Valencia, Spain.

Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

出版信息

Leukemia. 2024 Nov;38(11):2483-2486. doi: 10.1038/s41375-024-02389-2. Epub 2024 Aug 30.

DOI:10.1038/s41375-024-02389-2

PMID:39215061

Abstract

摘要

相似文献

Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.

Leukemia. 2024 Nov;38(11):2483-2486. doi: 10.1038/s41375-024-02389-2. Epub 2024 Aug 30.

Somatic mutations of calreticulin in myeloproliferative neoplasms.

N Engl J Med. 2013 Dec 19;369(25):2379-90. doi: 10.1056/NEJMoa1311347. Epub 2013 Dec 10.

The evolution and clinical relevance of prognostic classification systems in myelofibrosis.

Cancer. 2016 Mar 1;122(5):681-92. doi: 10.1002/cncr.29842. Epub 2015 Dec 30.

Targeted sequencing of candidate gene regions for myelofibrosis in dogs.

J Vet Intern Med. 2022 Jul;36(4):1237-1247. doi: 10.1111/jvim.16476. Epub 2022 Jul 11.

Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.

Platelets. 2014;25(7):539-47. doi: 10.3109/09537104.2013.840720. Epub 2013 Oct 31.

Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.

Br J Haematol. 2022 Nov;199(4):529-538. doi: 10.1111/bjh.18440. Epub 2022 Sep 12.

[Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology].

Zhonghua Xue Ye Xue Za Zhi. 2022 Apr 14;43(4):323-329. doi: 10.3760/cma.j.issn.0253-2727.2022.04.010.

Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report.

World J Clin Cases. 2024 May 26;12(15):2621-2626. doi: 10.12998/wjcc.v12.i15.2621.

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

Haematologica. 2008 Nov;93(11):1645-51. doi: 10.3324/haematol.13346. Epub 2008 Sep 11.

The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis.

Blood Coagul Fibrinolysis. 2016 Sep;27(6):648-52. doi: 10.1097/MBC.0000000000000446.

本文引用的文献

Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology.

Ann Hematol. 2024 Mar;103(3):737-747. doi: 10.1007/s00277-023-05610-x. Epub 2024 Jan 24.

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Leukemia. 2024 Feb;38(2):326-339. doi: 10.1038/s41375-023-02114-5. Epub 2023 Dec 27.

Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.

Br J Haematol. 2024 Jan;204(1):221-228. doi: 10.1111/bjh.19177. Epub 2023 Nov 2.

Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.

Br J Haematol. 2022 Nov;199(4):529-538. doi: 10.1111/bjh.18440. Epub 2022 Sep 12.

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.

Leukemia. 2022 Oct;36(10):2453-2460. doi: 10.1038/s41375-022-01673-3. Epub 2022 Aug 30.

JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.

Blood Cancer J. 2021 Dec 11;11(12):199. doi: 10.1038/s41408-021-00581-6.

Mutations and thrombosis in essential thrombocythemia.

Blood Cancer J. 2021 Apr 27;11(4):77. doi: 10.1038/s41408-021-00470-y.

Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of Mutations.

Cancers (Basel). 2020 Apr 10;12(4):934. doi: 10.3390/cancers12040934.

MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis.

J Clin Oncol. 2018 Jun 10;36(17):1769-1770. doi: 10.1200/JCO.2018.78.9867. Epub 2018 Apr 30.

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.

Blood Cancer J. 2017 Dec 27;7(12):662. doi: 10.1038/s41408-017-0035-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献